Sun Pharma Board Meeting Scheduled for 30th Oct'26 to Consider Q2 Results
Sun Pharmaceutical Industries Ltd 路 Intimation 路 30 Oct 2026, 5:30 am
Sun Pharma Board Meeting Scheduled for 30th Oct'26 to Consider Q2 Results Sun Pharmaceutical Industries announced that its Board of Directors will meet on 30th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for dealing in company securities, closed since 1st Oct'26, will remain shut until 1st Nov'26 (48 hours post-declaration of results).
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
